David B. Springgate
Keine laufenden Positionen mehr
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Bartlett | M | - |
University of Michigan
| 44 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Usama Mohammad Fayyad | M | 60 |
University of Michigan
| 11 Jahre |
| Sahijdak Walter | M | - |
University of Michigan
| 32 Jahre |
| George H. Vincent | M | - |
University of Michigan
| 7 Jahre |
| Izzet Garih | M | 63 |
University of Michigan
| 5 Jahre |
| Roger Foster | M | 77 |
Mylan Laboratories, Inc.
 Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | 23 Jahre |
| Prokopios Tsirigakis | M | 69 |
University of Michigan
| 5 Jahre |
| Charan Behl | M | 72 |
University of Michigan
| 5 Jahre |
| Barbara L. Silkworth | F | - |
University of Michigan
| 5 Jahre |
| Michael J. Barton | M | - |
University of Michigan
| 6 Jahre |
| Per A. Ramfjord | M | - |
University of Michigan
| 8 Jahre |
| Hung Shih | M | 68 |
University of Michigan
| 5 Jahre |
| Guru Kothandaraman | M | - |
University of Michigan
| 5 Jahre |
| Gil Syswerda | M | - |
University of Michigan
| 5 Jahre |
| Nuno María Pestana de Almeida Alves | M | 66 |
University of Michigan
| 7 Jahre |
| Kevin B. Hoppe | M | - |
University of Michigan
| 6 Jahre |
| Andrew B. Bressler | M | - |
University of Michigan
| 5 Jahre |
| Haluk Dinçer | M | 62 |
University of Michigan
| 6 Jahre |
| William R. Gillespie | M | - |
University of Michigan
| 4 Jahre |
| David M. di Rita | M | - |
University of Michigan
| 7 Jahre |
| Katherine A. Lauer | F | - |
University of Michigan
| 7 Jahre |
| Larry Barr | M | - |
University of Michigan
| 6 Jahre |
| Beverly J. Seay | F | - |
University of Michigan
| 6 Jahre |
| Karl R. Fink | M | - |
University of Michigan
| 7 Jahre |
| Kevyn Duane Orr | M | 66 |
University of Michigan
| 8 Jahre |
| Robert Barnett | M | - |
University of Michigan
| 7 Jahre |
| Lawrence Wieser | M | - |
University of Michigan
| 6 Jahre |
| Alex Horvitz | M | - |
University of Michigan
| 5 Jahre |
| Mary L. Campbell | F | - |
University of Michigan
| 2 Jahre |
| Paul F. DePond | M | 69 |
University of Michigan
| 5 Jahre |
| Elliot Noma | M | - |
University of Michigan
| 4 Jahre |
| Haithem Karim Sarafa | M | - |
University of Michigan
| 5 Jahre |
| Glenn P. Barba | M | 58 |
University of Michigan
| 5 Jahre |
| Daniel Hamburger | M | 60 |
University of Michigan
| 5 Jahre |
| Michael A. Sosin | M | 64 |
University of Michigan
| 8 Jahre |
| Louis J. DeBone | M | 78 |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | 30 Jahre |
| Stuart A. Williams | M | 69 |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | 3 Jahre |
| Mike Sayama | M | 69 |
University of Michigan
| 4 Jahre |
| Anmar Karim Sarafa | M | - |
University of Michigan
| 4 Jahre |
| Arthur Chadwick | M | 67 |
University of Michigan
| 6 Jahre |
| Jeffrey S. Geiger | M | 62 |
University of Michigan
| 5 Jahre |
| Alan Taetle | M | - |
University of Michigan
| 4 Jahre |
| Curt Hartman | M | 60 |
University of Michigan
| 4 Jahre |
| Charles K. Nicholas | M | - |
University of Michigan
| 4 Jahre |
| Jeffrey Steven Rosenberg | M | - |
University of Michigan
| 4 Jahre |
| Dilip K. Nigam | M | - |
University of Michigan
| 4 Jahre |
| James C. Romine | M | - |
University of Michigan
| 3 Jahre |
| Bruce R. Hill | M | - |
University of Michigan
| 4 Jahre |
| Tim Hurley | M | - |
University of Michigan
| 4 Jahre |
| David B. Papworth | M | 68 |
University of Michigan
| 4 Jahre |
| Manggi Taruna Habir | M | 71 |
University of Michigan
| 2 Jahre |
| Steven Jones | M | 59 |
University of Michigan
| 4 Jahre |
| Michael Thomas Seekell | M | - |
University of Michigan
| 4 Jahre |
| Pete Goettner | M | 60 |
University of Michigan
| 5 Jahre |
| Antonio J. Grillo-López | M | 84 |
University of Michigan
| 10 Jahre |
| David S. Smith | M | - |
University of Michigan
| 1 Jahre |
| Kim Cesare | F | - |
University of Michigan
| 4 Jahre |
| Alan F. Schultz | M | 65 |
University of Michigan
| 4 Jahre |
| Bruce Tanner | M | 65 |
University of Michigan
| 4 Jahre |
| Scott Canute | M | 63 |
University of Michigan
| 4 Jahre |
| Syed Hyder Ali | M | - |
University of Michigan
| 4 Jahre |
| Kazuhito Osugi | M | 70 |
University of Michigan
| 2 Jahre |
| Jeff Mackevich | M | - |
University of Michigan
| 4 Jahre |
| Scott L. Winkelman | M | - |
University of Michigan
| 4 Jahre |
| Paul H. Ray | M | 84 |
University of Michigan
| 8 Jahre |
| John Hogan | M | - |
University of Michigan
| 3 Jahre |
| Michael Joseph Stark | M | 68 |
University of Michigan
| 2 Jahre |
| Jeffrey Gould | M | 58 |
University of Michigan
| 4 Jahre |
| Richard Huey | M | - |
University of Michigan
| 4 Jahre |
| Christopher Ilitch | M | - |
University of Michigan
| 4 Jahre |
| Rob Furdak | M | - |
University of Michigan
| 4 Jahre |
| Peter Hoag | M | - |
University of Michigan
| 3 Jahre |
| David C. Bahls | M | - |
University of Michigan
| 4 Jahre |
| Raymond F. Mui | M | - |
University of Michigan
| 4 Jahre |
| David J. Rowland | M | - |
University of Michigan
| 4 Jahre |
| Timothy J. Abeska | M | - |
University of Michigan
| 4 Jahre |
| Michael P. Ashcraft | M | - |
University of Michigan
| 4 Jahre |
| Kevin Longe | M | 65 |
University of Michigan
| 4 Jahre |
| N. Prasad | M | 61 |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | - |
| David C. Walker | M | 63 |
University of Michigan
| 2 Jahre |
| Matthew Hilzinger | M | 61 |
University of Michigan
| 4 Jahre |
| John P. Barker | M | - |
University of Michigan
| 3 Jahre |
| David Kuehl | M | - |
University of Michigan
| 3 Jahre |
| Nancy Stuart | F | 65 |
University of Michigan
| 4 Jahre |
| Kenneth S. Duckworth | M | - |
University of Michigan
| 4 Jahre |
| Lawrence A. Schneider | M | - |
University of Michigan
| 4 Jahre |
| Mitchell L. Rippe | M | - |
University of Michigan
| 4 Jahre |
| Reuben Slone | M | 62 |
University of Michigan
| 4 Jahre |
| Mark Lundy | M | 61 |
University of Michigan
| 4 Jahre |
| Gregory Gallopoulos | M | 65 |
University of Michigan
| 4 Jahre |
| Jamey P. Weichert | M | 67 |
University of Michigan
| 3 Jahre |
| James D. Holzhauer | M | - |
University of Michigan
| 3 Jahre |
| Kenneth R. Fromm | M | - |
University of Michigan
| 4 Jahre |
| Sandra Metraux | F | - |
University of Michigan
| 2 Jahre |
| Matthew Gould | M | 64 |
University of Michigan
| 4 Jahre |
| Hank Barry | M | - |
University of Michigan
| 4 Jahre |
| James R. Downing | M | 69 |
University of Michigan
| 3 Jahre |
| Steven M. Fetter | M | 72 |
University of Michigan
| 3 Jahre |
| Jeffrey B. Yapp | M | 65 |
University of Michigan
| 4 Jahre |
| Lawrence Portnoy | M | - |
University of Michigan
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David B. Springgate
- Persönliches Netzwerk